Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.

Autor: Chiuppesi F; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA. flavia.chiuppesi@gmail.com., Zaia JA; Center for Gene Therapy, City of Hope National Medical Center, Duarte, CA, USA., Gutierrez-Franco MA; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Ortega-Francisco S; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Ly M; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Kha M; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Kim T; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Dempsey S; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Kar S; Bioqual, Rockville, MD, USA., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Wussow F; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA., Diamond DJ; Department of Hematology and HCT and Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, CA, USA.

Publikováno v: Communications medicine [Commun Med (Lond)] 2024 Feb 16; Vol. 4 (1), pp. 19. Date of Electronic Publication: 2024 Feb 16.